nafamostat has been researched along with Adenoma in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since hypercortisolism due to active Cushing's disease may worsen a COVID-19 infection, multi-disciplinary management that includes appropriate and prompt treatment strategies is mandatory in such cases." | 1.62 | Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. ( Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuno, A | 1 |
| Kenmotsu, Y | 1 |
| Takahashi, Y | 1 |
| Nomoto, H | 1 |
| Kameda, H | 1 |
| Cho, KY | 1 |
| Nakamura, A | 1 |
| Yamashita, Y | 1 |
| Nakamura, J | 1 |
| Nakakubo, S | 1 |
| Kamada, K | 1 |
| Suzuki, M | 1 |
| Sugino, H | 1 |
| Inoshita, N | 1 |
| Konno, S | 1 |
| Miyoshi, H | 1 |
| Atsumi, T | 1 |
| Sawamura, Y | 1 |
| Shimatsu, A | 1 |
1 other study available for nafamostat and Adenoma
| Article | Year |
|---|---|
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; C | 2021 |